532 related articles for article (PubMed ID: 15505841)
1. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
[TBL] [Abstract][Full Text] [Related]
4. Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes.
Lemos PA; van Mieghem CA; Arampatzis CA; Hoye A; Ong AT; McFadden E; Sianos G; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
Circulation; 2004 Jun; 109(21):2500-2. PubMed ID: 15148279
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of sirolimus-eluting stent implantation in diabetic patients with very small vessels (< or = 2.25 mm). Insights from the DIABETES trial].
Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; Gómez-Hospital JA; Sanmartín M; Bañuelos C; Moreno R; Escaned J; Fernández C; Costa MA; Fernández-Avilés F; Macaya C
Rev Esp Cardiol; 2006 Oct; 59(10):1000-7. PubMed ID: 17125709
[TBL] [Abstract][Full Text] [Related]
6. Comparison between drug-eluting stents and beta-radiation for the treatment of diffuse in-stent restenosis: clinical and angiographic outcomes.
Zavalloni D; Belli G; Rossi ML; Scatturin M; Morenghi E; Catalano G; Tosi G; Gasparini GL; Pagnotta P; Presbitero P
Am Heart J; 2006 Nov; 152(5):908.e1-7. PubMed ID: 17070155
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany Registry of Sirolimus for Unselected In-Stent Restenosis) Registry.
Liistro F; Fineschi M; Angioli P; Sinicropi G; Falsini G; Gori T; Ducci K; Bravi A; Bolognese L
J Am Coll Cardiol; 2006 Jul; 48(2):270-5. PubMed ID: 16843174
[TBL] [Abstract][Full Text] [Related]
9. Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.
Holmes DR; Teirstein P; Satler L; Sketch M; O'Malley J; Popma JJ; Kuntz RE; Fitzgerald PJ; Wang H; Caramanica E; Cohen SA;
JAMA; 2006 Mar; 295(11):1264-73. PubMed ID: 16531619
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial.
Hausleiter J; Kastrati A; Mehilli J; Vogeser M; Zohlnhöfer D; Schühlen H; Goos C; Pache J; Dotzer F; Pogatsa-Murray G; Dirschinger J; Heemann U; Schömig A;
Circulation; 2004 Aug; 110(7):790-5. PubMed ID: 15302787
[TBL] [Abstract][Full Text] [Related]
11. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
[TBL] [Abstract][Full Text] [Related]
13. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure.
Iakovou I; Sangiorgi GM; Stankovic G; Corvaja N; Michev I; Chieffo A; Rogacka R; Vitrella G; Airoldi F; Colombo A
Am J Cardiol; 2004 Aug; 94(3):351-4. PubMed ID: 15276103
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.
Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ
J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303
[TBL] [Abstract][Full Text] [Related]
17. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
[TBL] [Abstract][Full Text] [Related]
18. Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture.
Watanabe T; Tamura A; Miyamoto K; Kadota J
Int J Cardiol; 2010 Apr; 140(1):e12-3. PubMed ID: 19059662
[TBL] [Abstract][Full Text] [Related]
19. One-year results of the CRISTAL Trial, a randomized comparison of cypher sirolimus-eluting coronary stents versus balloon angioplasty for restenosis of drug-eluting stents.
Chevalier B; Moulichon R; Teiger E; Brunel P; Metzger JP; Pansieri M; Carrie D; Stoll HP; Wittebols K; Spaulding C; Fajadet J;
J Interv Cardiol; 2012 Dec; 25(6):586-95. PubMed ID: 22994863
[TBL] [Abstract][Full Text] [Related]
20. Clinical and angiographic follow-up after coronary drug-eluting and bare metal stent implantation. Do drug-eluting stents hold the promise?
Jensen J; Lagerqvist B; Aasa M; Särev T; Nilsson T; Tornvall P
J Intern Med; 2006 Aug; 260(2):118-24. PubMed ID: 16882275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
